title: Clinical course and CSF amyloid beta protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type.
authors.forename: K
authors.initials: K
authors.lastname: Urakami
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: A
authors.initials: A
authors.lastname: Okada
authors.forename: T
authors.initials: T
authors.lastname: Oshima
authors.forename: Y
authors.initials: Y
authors.lastname: Adachi
authors.forename: S
authors.initials: S
authors.lastname: Nakamura
authors.forename: N
authors.initials: N
authors.lastname: Kitaguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Tokushima
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000201:enzymology; D016564:Amyloid beta-Protein Precursor / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000378:metabolism*
chemical_list: D016564:Amyloid beta-Protein Precursor; D011480:Protease Inhibitors